DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
Abroad (travel likely)RecruitingPHASE4
Conditions
Atopic Dermatitis · Atopic Dermatitis Eczema
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Amsterdam University Medical Centers, Amsterdam, North Holland, Netherlands
Contact: Study coordinator (Anouk Caron, MD)Erasmus Medical Center, Rotterdam, South Holland, Netherlands
Study leads
Louise AA Gerbens, MD PhD
Study Chair
Amsterdam UMC, location VUmc
Phyllis I Spuls, MD PhD
Principal Investigator
Amsterdam UMC, location VUmc
DirkJan Hijnen, MD PhD
Principal Investigator
Erasmus Medical Center